Saniona ion channel research collaboration with Boehringer Ingelheim advances to next stage
By, Admin1 min read
Share
Saniona, a clinical stage biopharmaceutical company focused on rare diseases, today announced that its ongoing ion channel research collaboration with Boehringer Ingelheim has advanced to the next stage.
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
